首页 | 本学科首页   官方微博 | 高级检索  
     

表皮生长因子受体抑制剂在胰腺癌治疗中的作用
引用本文:孙慧玲,熊光苏,吴叔明. 表皮生长因子受体抑制剂在胰腺癌治疗中的作用[J]. 国际消化病杂志, 2008, 28(6)
作者姓名:孙慧玲  熊光苏  吴叔明
作者单位:上海市消化疾病研究所,上海交通大学医学院附属仁济医院,200001;上海市消化疾病研究所,上海交通大学医学院附属仁济医院,200001;上海市消化疾病研究所,上海交通大学医学院附属仁济医院,200001
摘    要:
胰腺癌是常见的消化道恶性肿瘤,传统的化疗和放疗效果均不甚理想。表皮生长因子受体(EGFR)信号转导通路在胰腺癌细胞的增殖、转移、血管形成等方面有重要作用,因此,针对EGFR信号通路的新型药物已陆续开发和应用。此文综述了EGFR的结构、功能以及EGFR抑制剂在胰腺癌治疗中的作用。

关 键 词:表皮生长因子受体  胰腺癌  EGFR抑制剂

The role of the epidermal growth factor receptor inhibitors in the treatment of pancreatic carcinoma
SUN Hui-ling,XIONG Guang-su,WU Shu-ming. The role of the epidermal growth factor receptor inhibitors in the treatment of pancreatic carcinoma[J]. International Journal of Digestive Disease, 2008, 28(6)
Authors:SUN Hui-ling  XIONG Guang-su  WU Shu-ming
Abstract:
Pancreatic carcinoma is an unusually gastroenterology tumor and to date treatment with standard chemotherapy has yielded disappointing results.The epidermal growth factor receptor(EGFR)is over-expressed and plays an important role in proliferation,migration,neo-vascularization.Novel antineoplastics are developed by preferentially targeting inhibition of EGFR.The structures and functions of EGFR as well as current status of EGFR inhibitors are reviewed.
Keywords:EGFR  Pancreatic cancer  EGFR inhibitors
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号